NervGen Pharma Corp.
NGEN:TSX.V; NGENF:OTCQX
NervGen is a publicly traded biotech company dedicated to discovering and developing treatments for patients suffering from medical conditions related to nerve damage.
Streetwise Company Fact Sheet2025/12/18 6:45:47
(NGEN:TSX.V - NGENF:OTCQX)
Newsletter coverage
| — |
Streetwise Reports Articles
| 12/16/2025 - View Article |
| 06/11/2024 - View Article |
Streetwise - NervGen Pharma Corp. Ownership Overview*
NervGen Pharma Corp. (NGEN:TSX.V; NGENF:OTCQX)
*Share Structure as of 6/11/2024
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
